본문 바로가기

METTL3-mediated downregulation of splicing factor SRSF11 is associated with carcinogenesis and poor survival of cancer patients

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
피인용
Web of Science 12Scopus 13
FWCI (Scopus)
1.79
JCR IF
JCR 2022 3.3
ISSN
1128-3602

저자

  1. Oh, J.제1저자Seoul Natl Univ, Coll Med, Dept Translat Med, Seoul, South Korea
  2. 오정민교신저자Pusan Natl Univ, Dent & Life Sci Inst, Sch Dent, Dept Oral Biochem, Yangsan, South Korea
  3. Cho, S. -y.교신저자Seoul Natl Univ, Coll Med, Dept Translat Med, Seoul, South Korea

초록

- OBJECTIVE: N6-methyladenos-ine (m6A) is one of the most abundant post-tran-scriptional modifications in eukaryotic RNA. As m6A modifications play an important role in RNA processing, abnormal m6A regulation caused by aberrant expression of m6A regulators is close-ly related to carcinogenesis. In this study, we aimed to determine the role of METTL3 expres-sion in carcinogenesis, regulation of splicing factor expression by METTL3, and their effects in survival period and cancer-related metabo-lisms. MATERIALS AND METHODS: We investigat-ed the correlation between each splicing fac-tor and METTL3 in breast invasive ductal carci-noma (BRCA), colon adenocarcinoma (COAD), lung adenocarcinoma (LUAD) and gastric ade-nocarcinoma (STAD). Survival analysis was per-formed based on the expression of each splicing factor. To determine the molecular mechanism of SRSF11 in carcinogenesis, gene set enrich-ment analysis using RNA sequencing data was performed according to SRSF11 expression. RESULTS: Among the 64 splicing factors used for correlation analysis, 13 splicing fac-tors showed a positive correlation with MET-TL3 in all four cancer types. We found that when METTL3 expression was decreased, the expres-sion of SRSF11 was also decreased in all four types of cancer tissue when compared to that in normal tissue. Decreased SRSF11 expression was associated with poor survival in patients with BRCA, COAD, LUAD, and STAD. Gene set enrichment analysis according to SRSF11 ex-pression showed that the p53/apoptosis, inflam- mation/immune response, and ultraviolet/reac-tive oxygen species stimulus-response path-ways were enriched in cancers with decreased SRSF11 expression. CONCLUSIONS: These results suggest that METTL3 regulates SRSF11 expression, which could influence mRNA splicing in m6A modified cancer cells. METTL3-mediated downregulation of SRSF11 expression in cancer patients cor-relates with poor prognosis.

키워드

Methyltransferase-like 3RNA splicingCarcinogen-esisSplicing factorSRSF11NUCLEAR-RNARECOGNITIONTRANSLATIONMUTATIONS

식별자

Scopus EID
2-s2.0-85151739831
WoS UID
000971936600040